Sulistiyati Bayu Utami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sulistiyati Bayu Utami has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Makoto Hosoyamada
Teikyo University
4 shared publicationsChishio Munemura
Tottori University Faculty of Medicine
3 shared publicationsHaruaki Ninomiya
Tottori University Faculty of Medicine
3 shared publicationsIchiro Hisatome
Tottori University Graduate School of Medical Science
3 shared publicationsKazuhiro Yamamoto
Tottori University
3 shared publications- Satrio Adi Wicaksono
Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia
3 shared publications
Latest Publications
- Open Access
- 16 May 2023
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (3) , 2521-2526
The immediate effects of Porang-processed rice (Amorphophallus muelleri) on triglyceride levels in patients with type 2 diabetes mellitus and dyslipidemia
Link of Video https://youtu.be/HSObtemRZ0M Background: Diabetes Mellitus (DM) is a major cause of death and disability worldwide. Diabetes mellitus is related to metabolic disorders in glucose and lipid levels. Porang tubers contain glucomannan, a substance with many health benefits, such as ameliorating blood glucose and lipid profiles, and has been processed as many food products, such as porang-processed rice (PR). This study investigated the immediate effects of PR on triglyceride levels compared to white rice (WR) in patients with diabetes mellitus (DM) and dyslipidemia. Methods: It was a randomized clinical study with an experimental pre-and post-test control group design held from October to November 2021 in Diponegoro National Hospital, Semarang, Indonesia. A total of 24 study subjects were selected by consecutive sampling. The inclusion criteria were (1) patients diagnosed with diabetes mellitus (DM) or who have been consuming routine oral antidiabetic drugs and (2) have signed the written informed consent. These subjects were divided into 2 groups, i.e., the treatment group (n=12) and the control group (n=12). The treatment group was given a porang rice (PR) diet of 300 grams, 3 times a day, for 5 days. The control group will consume a white rice (WR) diet for 5 days. Triglyceride levels were measured and compared between both groups before and after the treatment. Triglyceride levels were measured using venous blood sampling. All subjects were still consuming routine medications during the study. Results: There were no differences in participants' baseline demographic and clinical characteristics. At pre-treatment, there was no significant difference in triglyceride levels between the group with PR and WR (201.5 ± 102.29 vs 220.8 ± 92.08; respectively, p=0.564). At post-treatment, there was no significant difference in triglyceride levels between the group with PR and that with WR (200.0 ± 90.67 vs 224.3 ± 88.03; respectively, p=0.513). However, there was a larger decrease of triglyceride levels (Δtriglyceride) in a group with PR compared to that with WR (29.4 ± 22.81 vs 12.6 ± 7.12; p=0.016). Conclusion: There were no significant differences in the triglyceride levels before and after porang-processed rice (PR) or white rice (WR) in patients with DM and dyslipidemia. However, there was a larger decrease in triglyceride levels (Δtriglyceride) in a group with PR compared to that with WR. If confirmed by further studies, porang-processed rice might have the role of nutraceutical plants in stabilizing lipid profiles, especially triglyceride levels, in patients with DM and dyslipidemia.
- 16 May 2023
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (3) , 2521-2526
Open AccessThe immediate effects of Porang-processed rice (Amorphophallus muelleri) on triglyceride levels in patients with type 2 diabetes mellitus and dyslipidemia
Link of Video https://youtu.be/HSObtemRZ0M Background: Diabetes Mellitus (DM) is a major cause of death and disability worldwide. Diabetes mellitus is related to metabolic disorders in glucose and lipid levels. Porang tubers contain glucomannan, a substance with many health benefits, such as ameliorating blood glucose and lipid profiles, and has been processed as many food products, such as porang-processed rice (PR). This study investigated the immediate effects of PR on triglyceride levels compared to white rice (WR) in patients with diabetes mellitus (DM) and dyslipidemia. Methods: It was a randomized clinical study with an experimental pre-and post-test control group design held from October to November 2021 in Diponegoro National Hospital, Semarang, Indonesia. A total of 24 study subjects were selected by consecutive sampling. The inclusion criteria were (1) patients diagnosed with diabetes mellitus (DM) or who have been consuming routine oral antidiabetic drugs and (2) have signed the written informed consent. These subjects were divided into 2 groups, i.e., the treatment group (n=12) and the control group (n=12). The treatment group was given a porang rice (PR) diet of 300 grams, 3 times a day, for 5 days. The control group will consume a white rice (WR) diet for 5 days. Triglyceride levels were measured and compared between both groups before and after the treatment. Triglyceride levels were measured using venous blood sampling. All subjects were still consuming routine medications during the study. Results: There were no differences in participants' baseline demographic and clinical characteristics. At pre-treatment, there was no significant difference in triglyceride levels between the group with PR and WR (201.5 ± 102.29 vs 220.8 ± 92.08; respectively, p=0.564). At post-treatment, there was no significant difference in triglyceride levels between the group with PR and that with WR (200.0 ± 90.67 vs 224.3 ± 88.03; respectively, p=0.513). However, there was a larger decrease of triglyceride levels (Δtriglyceride) in a group with PR compared to that with WR (29.4 ± 22.81 vs 12.6 ± 7.12; p=0.016). Conclusion: There were no significant differences in the triglyceride levels before and after porang-processed rice (PR) or white rice (WR) in patients with DM and dyslipidemia. However, there was a larger decrease in triglyceride levels (Δtriglyceride) in a group with PR compared to that with WR. If confirmed by further studies, porang-processed rice might have the role of nutraceutical plants in stabilizing lipid profiles, especially triglyceride levels, in patients with DM and dyslipidemia.
- Open Access
- 5 December 2022
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (1) , 1041-1048
Clonidine premedication was better in preventing hemodynamic response changes post laryngoscopy and endotracheal intubation compared to fentanyl premedication
Background: Airway control under general anesthesia can be performed using laryngoscopy and endotracheal intubation. Laryngoscopy and endotracheal intubation produce mechanical and chemical stimuli that increase sympatho-adrenergic activity, causing an increased hemodynamic response. Various pharmacological and non-pharmacological methods have been used to reduce the response of hemodynamic changes in laryngoscopy and endotracheal intubation, such as fentanyl and clonidine. This study aimed to compare the effectiveness of fentanyl and clonidine in reducing hemodynamic response changes after laryngoscopy and endotracheal intubation. Methods: A double-blind randomized clinical trial was conducted on 48 elective surgery patients in the Surgical Installation of Dr. Kariadi General Hospital and Diponegoro National Hospital Semarang who were planned for laryngoscopy and endotracheal intubation procedures. Subjects were randomized and divided into 2 groups. Group 1 was administered with 2 µg/kgBW intravenous fentanyl premedication and group II was administered with 1 µg/kgBW intravenous clonidine premedication 5 minutes before the laryngoscopy and endotracheal intubation procedure. At baseline and at 1, 3, and 5 minutes after laryngoscopy and endotracheal intubation, the systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and heart rate (HR) were recorded simultaneously. Results: Both fentanyl and clonidine could maintain SBP, DBP, MAP, and HR within normal range. However, clonidine premedication seemed to be better in preventing hemodynamic response changes post-laryngoscopy and endotracheal intubation compared to fentanyl premedication. Clonidine premedication showed lower SBP, DBP, and MAP, but not HR, at the 1st and 3rd-minute post laryngoscopy and endotracheal intubation in comparison with fentanyl premedication (p<0.05). Conclusion: If confirmed by further findings, clonidine premedication may be preferable to prevent hemodynamic changes after laryngoscopy and endotracheal intubation.
- 5 December 2022
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (1) , 1041-1048
Open AccessClonidine premedication was better in preventing hemodynamic response changes post laryngoscopy and endotracheal intubation compared to fentanyl premedication
Background: Airway control under general anesthesia can be performed using laryngoscopy and endotracheal intubation. Laryngoscopy and endotracheal intubation produce mechanical and chemical stimuli that increase sympatho-adrenergic activity, causing an increased hemodynamic response. Various pharmacological and non-pharmacological methods have been used to reduce the response of hemodynamic changes in laryngoscopy and endotracheal intubation, such as fentanyl and clonidine. This study aimed to compare the effectiveness of fentanyl and clonidine in reducing hemodynamic response changes after laryngoscopy and endotracheal intubation. Methods: A double-blind randomized clinical trial was conducted on 48 elective surgery patients in the Surgical Installation of Dr. Kariadi General Hospital and Diponegoro National Hospital Semarang who were planned for laryngoscopy and endotracheal intubation procedures. Subjects were randomized and divided into 2 groups. Group 1 was administered with 2 µg/kgBW intravenous fentanyl premedication and group II was administered with 1 µg/kgBW intravenous clonidine premedication 5 minutes before the laryngoscopy and endotracheal intubation procedure. At baseline and at 1, 3, and 5 minutes after laryngoscopy and endotracheal intubation, the systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and heart rate (HR) were recorded simultaneously. Results: Both fentanyl and clonidine could maintain SBP, DBP, MAP, and HR within normal range. However, clonidine premedication seemed to be better in preventing hemodynamic response changes post-laryngoscopy and endotracheal intubation compared to fentanyl premedication. Clonidine premedication showed lower SBP, DBP, and MAP, but not HR, at the 1st and 3rd-minute post laryngoscopy and endotracheal intubation in comparison with fentanyl premedication (p<0.05). Conclusion: If confirmed by further findings, clonidine premedication may be preferable to prevent hemodynamic changes after laryngoscopy and endotracheal intubation.
- Open Access
- 14 June 2022
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 11 (2) , 573-578
The Immediate Effects of Porang-Processed Rice (Amorphophallus oncophyllus) on Blood Glucose Levels in Patients with Type 2 Diabetes Mellitus
Background: Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia and associated with several risk factors, such as an unhealthy and unbalanced diet. Porang tubers, known as healthy diet resources, contain glucomannan, a substance that has many positive effects, such as ameliorating blood glucose. Porang tubers are processed as many food products, one of which is porang-processed rice (PR). This study investigated the immediate effects of PR on the blood glucose levels compared to white rice (WR) in patients with diabetes mellitus (DM). Methods: This was a pilot study of a non-randomized clinical study with a pre-and post-test design held from July to August 2021 in Diponegoro National Hospital, Semarang, Indonesia, among 40 DM patients. Subjects who met the inclusion criteria were divided into two groups: subjects that consumed Porang-processed rice (PR group, n=20) for two days and those that consumed white rice (WR group, n=20). They were measured for fasting blood glucose (FBG) and 2 hours post-prandial glucose (2hPPG) at baseline (T0) and at day-3 after observation (T1). Data were analyzed using SPSS version 20 for Windows. Results: There were no significant differences in FBG and 2hPPG between the PR group and WR group at T0 and T1 (p>0.05). However, there were slightly larger decreases in FBG and 2hPPG in the PR group compared to the WR group, although they were insignificant (p>0.05). Conclusion: The immediate consumption of PR for only two days in patients with DM could not reduce FPG and 2hPPG. It is needed to be confirmed by further studies whether PR may have the role as adjunctive in inhibiting the dramatic rise of FBG or 2hPPG or stabilizing blood glucose in patients with DM in a more extended time of consumption.
- 14 June 2022
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 11 (2) , 573-578
Open AccessThe Immediate Effects of Porang-Processed Rice (Amorphophallus oncophyllus) on Blood Glucose Levels in Patients with Type 2 Diabetes Mellitus
Background: Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia and associated with several risk factors, such as an unhealthy and unbalanced diet. Porang tubers, known as healthy diet resources, contain glucomannan, a substance that has many positive effects, such as ameliorating blood glucose. Porang tubers are processed as many food products, one of which is porang-processed rice (PR). This study investigated the immediate effects of PR on the blood glucose levels compared to white rice (WR) in patients with diabetes mellitus (DM). Methods: This was a pilot study of a non-randomized clinical study with a pre-and post-test design held from July to August 2021 in Diponegoro National Hospital, Semarang, Indonesia, among 40 DM patients. Subjects who met the inclusion criteria were divided into two groups: subjects that consumed Porang-processed rice (PR group, n=20) for two days and those that consumed white rice (WR group, n=20). They were measured for fasting blood glucose (FBG) and 2 hours post-prandial glucose (2hPPG) at baseline (T0) and at day-3 after observation (T1). Data were analyzed using SPSS version 20 for Windows. Results: There were no significant differences in FBG and 2hPPG between the PR group and WR group at T0 and T1 (p>0.05). However, there were slightly larger decreases in FBG and 2hPPG in the PR group compared to the WR group, although they were insignificant (p>0.05). Conclusion: The immediate consumption of PR for only two days in patients with DM could not reduce FPG and 2hPPG. It is needed to be confirmed by further studies whether PR may have the role as adjunctive in inhibiting the dramatic rise of FBG or 2hPPG or stabilizing blood glucose in patients with DM in a more extended time of consumption.
- 20 September 2014
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 19 (4) , 576-584
Apoptosis induced by an uromodulin mutant C112Y and its suppression by topiroxostat
- 20 September 2014
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 19 (4) , 576-584
Apoptosis induced by an uromodulin mutant C112Y and its suppression by topiroxostat
- 14 August 2012
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 45 (01) , 69-73
A Vasodilating β1 Blocker Celiprolol Inhibits Muscular Release of Uric Acid Precursor in Patients with Essential Hypertension
Although nonvasodilating β1 blockers increase the levels of uric acid in serum, it is not known whether vasodilating β1 blockers have a similar effect. In the present study, we evaluated the effect of celiprolol on the release of hypoxanthine, a uric acid precursor, from muscles after an exercise. We used the semi-ischemic forearm test to examine the release of lactate (ΔLAC), ammonia (ΔAmm), and hypoxanthine (ΔHX) before and 4, 10, and 60 min after an exercise in 18 hypertensive patients as well as 4 normotensive subjects. Before celiprolol treatment, all the levels of ΔHX and ΔAmm, and ΔLAC were increased by semi-ischemic exercise in hypertensive patients, and the increases were remarkably larger than those in normotensive subjects. Celiprolol decreased both systolic and diastolic pressure. It also decreased the levels of ΔHX and ΔAmm without changes in ΔLAC after an exercise. These findings also were confirmed by summation of each metabolite (ΣΔMetabolites). Celiprolol caused a marginal decrease of serum uric acid, but the difference was not statistically significant. On the other hand, nonvasodilating β1 blockers did not suppress the levels of ΔHX and ΔAmm, whereas they significantly increased ΔLAC after an exercise. Celiprolol improved energy metabolism in skeletal muscles. It suppressed HX production and consequently did not adversely affect serum uric acid levels. * E. Mizuta and S. B. Utami contributed equally to this project.
- 14 August 2012
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 45 (01) , 69-73
A Vasodilating β1 Blocker Celiprolol Inhibits Muscular Release of Uric Acid Precursor in Patients with Essential Hypertension
Although nonvasodilating β1 blockers increase the levels of uric acid in serum, it is not known whether vasodilating β1 blockers have a similar effect. In the present study, we evaluated the effect of celiprolol on the release of hypoxanthine, a uric acid precursor, from muscles after an exercise. We used the semi-ischemic forearm test to examine the release of lactate (ΔLAC), ammonia (ΔAmm), and hypoxanthine (ΔHX) before and 4, 10, and 60 min after an exercise in 18 hypertensive patients as well as 4 normotensive subjects. Before celiprolol treatment, all the levels of ΔHX and ΔAmm, and ΔLAC were increased by semi-ischemic exercise in hypertensive patients, and the increases were remarkably larger than those in normotensive subjects. Celiprolol decreased both systolic and diastolic pressure. It also decreased the levels of ΔHX and ΔAmm without changes in ΔLAC after an exercise. These findings also were confirmed by summation of each metabolite (ΣΔMetabolites). Celiprolol caused a marginal decrease of serum uric acid, but the difference was not statistically significant. On the other hand, nonvasodilating β1 blockers did not suppress the levels of ΔHX and ΔAmm, whereas they significantly increased ΔLAC after an exercise. Celiprolol improved energy metabolism in skeletal muscles. It suppressed HX production and consequently did not adversely affect serum uric acid levels. * E. Mizuta and S. B. Utami contributed equally to this project.
- Open Access
- 1 January 2011
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 34 (9) , 1474-1480
Novel Effects of Extracts from Poisonous Mushrooms on Expression and Function of the Human ether-a-go-go-Related Gene Channel
The human ether-a-go-go-related gene (hERG) encodes the α subunit of the potassium current IKr, which plays a pivotal role in cardiac action potential repolarization. Inherited mutations of this gene cause Long QT syndrome type 2. hERG expression is altered by several types of drugs as well as by temperature. Heat shock protein 70 (Hsp70) and Heat shock cognate protein 70 (Hsc70) have reciprocal effects on hERG proteins. We examined the effects of poisonous mushrooms on hERG protein expression and its channel function. Methods: We evaluated the effects of several types of poisonous mushrooms on the expression and function of wild-type hERG by Western blotting, reverse transcription polymerase chain reaction (PCR), and patch clamping in transfected HEK293 cells and mouse HL-1 cardiomyocytes. Results: Extracts of Gymnopilus junonius (junonius) increased expression of both hERG and Hsp70 in HEK293 cells with concomitant decrease in Hsc70, whereas extracts of Amanita ibotengutake (ibotengutake) decreased hERG proteins with increase in Hsc70. Knockdown of Hsp70 and Hsc70 by small interfering RNA abolished the effects of the two mushrooms on hERG, respectively. Certain fractions of junonius increased expression of hERG proteins. hERG currents were increased by extracts of junonius, resulting in shortening of action potential duration (APD). In contrast, hERG currents were decreased and APD was prolonged by extracts of ibotengutake. Conclusion: junonius enhanced the expression and function of hERG by increasing Hsp70 and decreasing Hsc70. Ibotengutake decreased hERG expression via increase in Hsc70. Constituents of junonius may have the potential for use in treatment of arrhythmia.
- 1 January 2011
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 34 (9) , 1474-1480
Open AccessNovel Effects of Extracts from Poisonous Mushrooms on Expression and Function of the Human ether-a-go-go-Related Gene Channel
The human ether-a-go-go-related gene (hERG) encodes the α subunit of the potassium current IKr, which plays a pivotal role in cardiac action potential repolarization. Inherited mutations of this gene cause Long QT syndrome type 2. hERG expression is altered by several types of drugs as well as by temperature. Heat shock protein 70 (Hsp70) and Heat shock cognate protein 70 (Hsc70) have reciprocal effects on hERG proteins. We examined the effects of poisonous mushrooms on hERG protein expression and its channel function. Methods: We evaluated the effects of several types of poisonous mushrooms on the expression and function of wild-type hERG by Western blotting, reverse transcription polymerase chain reaction (PCR), and patch clamping in transfected HEK293 cells and mouse HL-1 cardiomyocytes. Results: Extracts of Gymnopilus junonius (junonius) increased expression of both hERG and Hsp70 in HEK293 cells with concomitant decrease in Hsc70, whereas extracts of Amanita ibotengutake (ibotengutake) decreased hERG proteins with increase in Hsc70. Knockdown of Hsp70 and Hsc70 by small interfering RNA abolished the effects of the two mushrooms on hERG, respectively. Certain fractions of junonius increased expression of hERG proteins. hERG currents were increased by extracts of junonius, resulting in shortening of action potential duration (APD). In contrast, hERG currents were decreased and APD was prolonged by extracts of ibotengutake. Conclusion: junonius enhanced the expression and function of hERG by increasing Hsp70 and decreasing Hsc70. Ibotengutake decreased hERG expression via increase in Hsc70. Constituents of junonius may have the potential for use in treatment of arrhythmia.
- 1 April 2010
- Published by Georg Thieme Verlag KG in Arzneimittelforschung
- Vol. 60 (04) , 186-188
Effect of losartan and benzbromarone on the level of human urate transporter 1 mRNA
Both an angiotensin II receptor blocker, losartan (CAS 124750-99-8) and a serum urate lowering agent, benzbromarone (CAS 3562-84-3) exert a uricosuric action by inhibiting urate transporter 1 (URAT1). A recent clinical trial indicated that losartan could reduce the level of serum urate in hypertensive patients treated with urate lowering agents, suggesting the different mode of action of losartan from benzbromarone. In the present study, the effect of losartan and benzbromarone on the level of URAT1 mRNA was determined in transfected HEK293 cells. Losartan caused a significant reduction of its mRNA level, whereas it was not affected by benzbromarone. These results indicate that losartan decreases the level of human URAT1 mRNA, which may underlie the uricosuric action of losartan in hypertensive patients treated with serum urate lowering agents.
- 1 April 2010
- Published by Georg Thieme Verlag KG in Arzneimittelforschung
- Vol. 60 (04) , 186-188
Effect of losartan and benzbromarone on the level of human urate transporter 1 mRNA
Both an angiotensin II receptor blocker, losartan (CAS 124750-99-8) and a serum urate lowering agent, benzbromarone (CAS 3562-84-3) exert a uricosuric action by inhibiting urate transporter 1 (URAT1). A recent clinical trial indicated that losartan could reduce the level of serum urate in hypertensive patients treated with urate lowering agents, suggesting the different mode of action of losartan from benzbromarone. In the present study, the effect of losartan and benzbromarone on the level of URAT1 mRNA was determined in transfected HEK293 cells. Losartan caused a significant reduction of its mRNA level, whereas it was not affected by benzbromarone. These results indicate that losartan decreases the level of human URAT1 mRNA, which may underlie the uricosuric action of losartan in hypertensive patients treated with serum urate lowering agents.